Invention Grant
- Patent Title: Combination therapy using azabicyclo compound for cancer
-
Application No.: US15025797Application Date: 2014-09-29
-
Publication No.: US09694001B2Publication Date: 2017-07-04
- Inventor: Hiromi Muraoka , Akira Kanoh
- Applicant: TAIHO PHARMACEUTICAL CO., LTD.
- Applicant Address: JP Chiyoda-ku
- Assignee: TAIHO PHARMACEUTICAL CO., LTD.
- Current Assignee: TAIHO PHARMACEUTICAL CO., LTD.
- Current Assignee Address: JP Chiyoda-ku
- Agency: Oblon, McClelland, Maier & Neustadt, L.L.P.
- Priority: JP2013-205500 20130930
- International Application: PCT/JP2014/075846 WO 20140929
- International Announcement: WO2015/046498 WO 20150402
- Main IPC: A61K31/706
- IPC: A61K31/706 ; A61K31/437 ; A61K33/24 ; A61K45/06 ; A61K31/337 ; A61K31/454 ; A61K31/506 ; A61K31/517 ; A61K31/519 ; A61K31/5377 ; A61K31/704 ; A61K31/7048 ; A61K31/7068
Abstract:
Provided is a novel method for treating cancer using an HSP90 inhibitor which exhibits a markedly superior antitumor effect and has a reduced side effect.An antitumor agent is characterized in that an azabicyclo compound of the following Formula (1) or a salt thereof is administered in combination with other antitumor agent(s).
Public/Granted literature
- US20160228417A1 COMBINATION THERAPY USING AZABICYCLO COMPOUND FOR CANCER Public/Granted day:2016-08-11
Information query
